For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
What is the forecasted revenue size of the bioreactors industry by 2029?
The bioreactors market size has grown rapidly in recent years. It will grow from $9.22 billion in 2024 to $10.64 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, rise in cell and gene therapy research, growing focus on personalized medicine, adoption of single-use bioreactor technology, need for efficient manufacturing processes.
The bioreactors market size is expected to see rapid growth in the next few years. It will grow to $18.58 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to rising investment in biotechnology research, increasing prevalence of chronic diseases, growing demand for vaccines and therapeutic proteins, surge in regulatory support for biomanufacturing, increasing use of advanced therapies. Major trends in the forecast period include advancements in biotechnology, advancements in automation and control systems, rise in bioprocess development, advancements in manufacturing efficiency, growing need for scalable production solutions.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20721&type=smp
Which industry-specific innovations are acting as key drivers for the bioreactors market?
The increasing demand for biopharmaceuticals is expected to propel the growth of the bioreactors market going forward. Biopharmaceuticals are medicinal products derived from biological sources, such as proteins, cells, and living organisms, used to prevent, treat, or manage various diseases. The increasing demand for biopharmaceuticals is due to advancements in medical research, personalized medicine, and the need for innovative treatments, leading to improved healthcare outcomes worldwide. Bioreactors are useful for biopharmaceuticals as they enable efficient and scalable production of therapeutic products, ensuring consistent quality, reducing production costs, and facilitating the development of innovative and life-enhancing medicines. For instance, in May 2024, according to Pharmaceutical Research and Manufacturers of America, a US-based trade association, in 2022, the U.S. biopharmaceutical industry exceeded $1.65 trillion in total output, with $800 billion in direct production and an additional $800 billion through suppliers and other sectors, accounting for 3.6% of the U.S. economy. Therefore, increasing demand for biopharmaceuticals is driving growth in the bioreactors market.
Which segment currently leads the bioreactors market in terms of revenue share?
The bioreactors market covered in this report is segmented –
1) By Type Of Bioprocess: Batch And Fed-Batch, Continuous
2) By Cell: Mammalian Cells, Bacterial Cells, Yeast Cells, Other Cells
3) By Control: Manual, Automated
4) By Usage: Lab Scale Production, Pilot Scale Production, Full Scale Production
5) By End-Use: Research And Development (R&D) Organizations, Biopharmaceutical (Biopharma) Manufacturers, Contract Manufacturing Organizations (CMOS)
Subsegments:
1) By Batch And Fed-Batch: Traditional Batch Bioreactors, Fed-Batch Bioreactors
2) By Continuous: Perfusion Bioreactors, Continuous Stirred Tank Bioreactors (CSTR)
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/bioreactors-global-market-report
What future trends will impact the direction of the bioreactors industry?
Major companies operating in the bioreactors market are focusing on developing advanced products such as fixed-bed bioreactors to support the growth of more complex biological cultures. A fixed-bed bioreactor is a type of bioreactor in which biological organisms are attached to a solid support, typically composed of porous materials such as beads, fibers, or granules. This design enhances mass transfer, minimizes shear stress, and provides better control over the biological processes. For instance, in October 2024, Univercells Technologies, a Belgium-based biotechnology company, launched the Scale-X Nexo bioreactor. This cutting-edge bioreactor, featuring a 0.5 m² growth surface, is specifically designed to optimize cell culture process development, offering significant benefits for biopharmaceutical companies and research institutions. The scale-X nexo facilitates seamless scalability to larger models, reduces media and reagent consumption, and can lower operational costs by up to 60% compared to traditional entry-level bioreactors. Additionally, it integrates with the Skaia Vision application software, further boosting productivity by providing precise cell count estimations without the need for direct sampling.
Who are the top competitors in the global bioreactors market?
Major companies operating in the bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Cytiva Bioscience Holding Ltd., Sartorius AG, Cellexus Ltd., Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin, Broadley-James Corporation, PBS Biotech Inc., TAP Biosystems, Solida Biotech GmBH, BBI-Biotech GmbH, HiTec Zang GmbH, Xiamen Ollital Technology Co. Ltd., Bioengineering AG, Infors AG, Univercells Technologies SA, CerCell A/S, Bailun Biotechnology Co. Ltd., BioNet, Shanghai Ritai Medicine Equipment Project Co. Ltd.
What regional dynamics are shaping the future of the global bioreactors market?
North America was the largest region in the bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Bioreactors Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20721
Need Customized Data On Bioreactors Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20721&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
